OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
Jason J. Luke, Sarina A. Piha‐Paul, Theresa Medina, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 13, pp. 2435-2444
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Probiotic-guided CAR-T cells for solid tumor targeting
Rosa L. Vincent, Candice R. Gurbatri, Fangda Li, et al.
Science (2023) Vol. 382, Iss. 6667, pp. 211-218
Open Access | Times Cited: 83

Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27

Next generation probiotics: Engineering live biotherapeutics
Sanjeeva Kumar Murali, Thomas J. Mansell
Biotechnology Advances (2024) Vol. 72, pp. 108336-108336
Closed Access | Times Cited: 17

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors
Guohao Li, Xiangqian Zhao, Zuda Zheng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 12

Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 35

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities
Xu He, Abdalla M. Wedn, Jian Wang, et al.
Pharmacological Research (2024) Vol. 201, pp. 107063-107063
Open Access | Times Cited: 11

Engineering bacteria for cancer immunotherapy
Jesse G. Zalatan, Lorenzo Petrini, Roger Geiger
Current Opinion in Biotechnology (2024) Vol. 85, pp. 103061-103061
Open Access | Times Cited: 9

Engineered bacteria in tumor immunotherapy
Hua Chen, Yinrui Zhu, Chonghai Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216817-216817
Closed Access | Times Cited: 8

Engineering Strategies to Modulate the Gut Microbiome and Immune System
Kai Han, Jin Xu, Fang Xie, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 208-215
Closed Access | Times Cited: 7

Clinical landscape of macrophage-reprogramming cancer immunotherapies
Jenna H. Rannikko, Maija Hollmén
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 627-640
Open Access | Times Cited: 7

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
Jiawen Zhang, Sihui Yu, Qiao Peng, et al.
Cancer Biology and Medicine (2024), pp. 1-20
Open Access | Times Cited: 6

Delivery of STING agonists for cancer immunotherapy
Jianping Wang, Fanfei Meng, Yoon Yeo
Current Opinion in Biotechnology (2024) Vol. 87, pp. 103105-103105
Closed Access | Times Cited: 6

Innovative Applications of Bacteria and Their Derivatives in Targeted Tumor Therapy
Denghui Zhu, Wei Pan, Heqi Li, et al.
ACS Nano (2025)
Closed Access

Tumor microbiome: roles in tumor initiation, progression, and therapy
Shengxin Zhang, Jing Huang, Z. X. Jiang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access

Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies
Mingqing Huang, Zhuocen Cha, Rui Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma
Hinda Najem, Spencer Lea, Shashwat Tripathi, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 5

When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity
Dong Pan, Qi Wang, AiHua Shen, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 3, pp. 384-399
Closed Access | Times Cited: 4

cGAS-STING signaling pathway in intestinal homeostasis and diseases
Yuchen Yang, Li Wang, Ivonne Peugnet-González, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”
Xiangcheng Zhao, Nuli Xie, Hailong Zhang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2214-2214
Open Access | Times Cited: 11

The interplay between autophagy and cGAS-STING signaling and its implications for cancer
Maximilian Schmid, Patrick D. Fischer, Magdalena Engl, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases
Ruben Vazquez-Uribe, Karl Alex Hedin, Tine Rask Licht, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 4

Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses
Shaobo Yang, Michal Sheffer, Isabel E. Kaplan, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 3

Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies
Vishnu Raman, C. Deshpande, Shradha Khanduja, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 10, pp. 1574-1592
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top